Teva Pharma Industries Ltd ADR
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $4,142,000 | $3,981,000 | $4,711,000 | $4,480,000 |
Gross Profit | 2,153,000 | 1,972,000 | 2,656,000 | 2,304,000 |
EBITDA | -19,000 | 877,000 | 632,000 | 1,104,000 |
EBIT | -260,000 | 638,000 | 372,000 | 855,000 |
Net Income | -576,000 | 369,000 | 480,000 | 433,000 |
Net Change In Cash | 4,142,000 | 3,981,000 | 4,711,000 | 4,480,000 |
Free Cash Flow | 307,000 | -208,000 | 1,016,000 | 233,000 |
Cash | 3,655,000 | 3,741,044 | 3,556,000 | 2,203,000 |
Basic Shares | 1,181,000 | 1,179,000 | 1,173,000 | 1,164,000 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $17,257,000 | $16,544,000 | $15,846,000 | $14,925,000 |
Gross Profit | 8,938,000 | 8,063,000 | 7,645,000 | 6,973,000 |
EBITDA | 3,141,000 | 4,431,000 | 433,000 | -925,000 |
EBIT | 2,139,000 | 3,372,000 | 433,000 | -2,233,000 |
Net Income | 1,410,000 | -1,639,000 | -559,000 | -2,446,000 |
Net Change In Cash | 17,257,000 | 16,544,000 | 15,846,000 | 14,925,000 |
Free Cash Flow | 1,148,000 | 749,000 | 842,000 | 1,042,000 |
Cash | 3,555,945 | 3,300,000 | 3,226,000 | 2,801,000 |
Basic Shares | 1,173,000 | 1,131,000 | 1,119,000 | 1,110,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.64 |
2026-03-31 | $0.53 |
2025-12-31 | $0.96 |
2025-09-30 | $0.75 |